COVISHIELD finishes the enrollment of Phase III clinical trials under ICMR, SII collaboration
The Serum Institute of India (SII) with the collaboration of Indian Council of Medical Research (ICMR) have declared the completion of the total registration for the phase III clinical trials for COVISHIELD in India. As per an official release, SII and ICMR are also in a joint partnership for the clinical development of COVOVAX (Novovax)…